These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32464648)

  • 41. Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry.
    Phillips KP; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2020 Feb; 22(2):225-231. PubMed ID: 31665276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives.
    Mesnier J; Cepas-Guillén P; Freixa X; Flores-Umanzor E; Hoang Trinh K; O'Hara G; Rodés-Cabau J
    Circ Cardiovasc Interv; 2023 May; 16(5):e012812. PubMed ID: 37192309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: is left atrial appendage closure an alternative for anticoagulation?].
    Boersma LVA; Rensing BJWM; Wintgens LI; Klaver M; Swaans MJ
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device.
    Bösche LI; Afshari F; Schöne D; Ewers A; Mügge A; Gotzmann M
    Clin Cardiol; 2015 Dec; 38(12):720-4. PubMed ID: 26467851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
    Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
    Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left Atrial Appendage Closure in Patients With Atrial Fibrillation at Very High Bleeding Risk Without Postimplantation Antithrombotic Therapy.
    Darmon A; Couture EL; Stein G; Cormier B; Chevalier B; Lefèvre T; Sanguineti A; Horvilleur J; Garot P
    J Invasive Cardiol; 2020 Oct; 32(10):385-391. PubMed ID: 32999093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　- First Results From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Ootomo T; Takayama M; Ando K; Hirao K; Morino Y; Hayashida K; Kusano K; Main ML; Saito S
    Circ J; 2018 Nov; 82(12):2946-2953. PubMed ID: 30305484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
    Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
    Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single Versus Dual Antiplatelet Therapy following Left Atrial Appendage Occlusion in Patients With High Bleeding Risk.
    Mhanna M; Beran A; Al-Abdouh A; Jabri A; Al-Aaraj A; Sajdeya O; Abuhelwa Z; Khokher W; Bhuta S; Burmeister CJ; Eltahawy EA
    Curr Probl Cardiol; 2022 Sep; 47(9):101269. PubMed ID: 35644502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left atrial appendage closure for stroke prevention in atrial fibrillation: Final report from the French left atrial appendage closure registry.
    Teiger E; Thambo JB; Defaye P; Hermida JS; Abbey S; Klug D; Juliard JM; Spaulding C; Armero S; Champagnac D; Bhugaloo H; Ternacle J; Lellouche N; Audureau E; Le Corvoisier P;
    Catheter Cardiovasc Interv; 2021 Oct; 98(4):788-799. PubMed ID: 34051135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage.
    Hucker WJ; Cohen JA; Gurol ME; Heist EK; Gianni C; Galvin J; Atkins D; Bommana S; Di Biase L; Ruskin J; Mohanty S; Horton R; Lakkireddy D; Natale A; Mansour M
    J Interv Card Electrophysiol; 2020 Nov; 59(2):415-421. PubMed ID: 31833012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
    Reddy VY; Doshi SK; Sievert H; Buchbinder M; Neuzil P; Huber K; Halperin JL; Holmes D;
    Circulation; 2013 Feb; 127(6):720-9. PubMed ID: 23325525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation.
    Price MJ
    Prog Cardiovasc Dis; 2018; 60(4-5):542-549. PubMed ID: 29339165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.
    Boersma LV; Schmidt B; Betts TR; Sievert H; Tamburino C; Teiger E; Pokushalov E; Kische S; Schmitz T; Stein KM; Bergmann MW;
    Eur Heart J; 2016 Aug; 37(31):2465-74. PubMed ID: 26822918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry.
    Phillips KP; Santoso T; Sanders P; Alison J; Chan JLK; Pak HN; Chandavimol M; Stein KM; Gordon N; Razali OB
    Int J Cardiol Heart Vasc; 2019 Jun; 23():100358. PubMed ID: 31008181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcomes and periprocedural safety and efficacy of percutaneous left atrial appendage closure in a United Kingdom tertiary center: An 11-year experience.
    Briosa E Gala A; Pope MTB; Monteiro C; Leo M; Dawkins S; Newton JD; Betts TR
    Heart Rhythm; 2021 Oct; 18(10):1724-1732. PubMed ID: 34126270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.